CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-05-24 18:44 Tx date 2024-05-23	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$219,760 +67,000 vol $3.28 each	273,000
Filed 2023-05-26 17:25 Tx date 2023-05-24	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$140,800 +55,000 vol $2.56 each	206,000
Filed 2022-05-26 22:00 Tx date 2022-05-25	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$92,250 +41,000 vol $2.25 each	151,000
Filed 2021-06-07 20:22 Tx date 2021-06-03	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$64,900 +22,000 vol $2.95 each	110,000
Filed 2020-06-01 17:35 Tx date 2020-05-28	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$47,520 +22,000 vol $2.16 each	88,000
Filed 2019-08-22 12:55 Tx date 2019-08-17	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$33,000 +22,000 vol $1.50 each	66,000
Filed 2018-11-26 Tx date 2018-11-26	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Convertible Preferred Shares Series A 00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26 Tx date 2018-11-26	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$207,680 +44,000 vol $4.72 each	44,000
Filed 2018-11-26 Tx date 2018-11-26	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26 Tx date 2018-11-26	$ABUS Arbutus Biopharma Corporation	Torti, Frank 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report